Delivery Order SPE2DB22D1202-SPE2DB24FUSU9
Award Date 3/6/24
Potential Completion Date 3/7/24
Potential Value $3.9K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Glimepiride 4 mg tablets, a medication used to treat diabetes. The contract has a total ceiling value of $2,521.04 and a period of performance through December 6, 2023. The contract is a firm-fixed-price type, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays...
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Glimepiride 4 mg tablets, a diabetes medication, with a ceiling value of $2,043.05 and a completion date of July 2, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and holds a larger...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award has a ceiling value of $2,076.00 and covers the delivery of Glimepiride 4 mg tablets. The contract is a firm fixed-price delivery order with an ultimate completion date of January 27, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4 mg Glimepiride tablets, a medication used to treat diabetes. The contract has a completion date of December 4, 2023, and a ceiling value of $3,745.96. It is a Firm Fixed Price Delivery Order contract, without any set-aside designation. AmerisourceBergen Drug Corp is a subsidiary of the parent...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GLIMEPIRIDE 4 MG TABLET 100S, a diabetes medication, with a ceiling value of $4,037.26 and a completion date of July 10, 2025. The contract is a firm fixed-price, non-set-aside delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Glimepiride 2 mg tablets, a medication used to treat type 2 diabetes. The contract has a ceiling value of $1,451.32 and a period of performance through April 28, 2025. It is a firm fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Glimepiride 4 mg tablets. The contract is a firm-fixed-price delivery order with a ceiling value of $4,080.24 and has an ultimate completion date of September 5, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract with the DLA Troop Support Medical valued at $999,999,999, which...
- This federal contract award, with an ID of SPE2DB20D1051|SPE2DB24FD7FS, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Glimepiride 4 mg tablets, a medication used to treat diabetes. The award has a ceiling value of $2,778.33 and an ultimate completion date of March 7, 2024. This contract is a delivery order, with a firm fixed-price pricing type. The contract is not designated as a set-aside....
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of glimepiride 4 mg tablets in 100-count bottles. The contract has a ceiling value of $2,106.69 and is a firm-fixed-price delivery order contract with a period of performance through May 28, 2025. The contract is not set aside and allows for the provision of both brand-name and generic medications to...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the supply of GLIMEPIRIDE 4 MG TABLET 100S, a pharmaceutical product, with a ceiling value of $1,756.55 and a performance period through June 6, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a key vendor for federal healthcare programs,...